A detailed history of Comerica Bank transactions in Liquidia Corp stock. As of the latest transaction made, Comerica Bank holds 127 shares of LQDA stock, worth $1,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127
Previous 87 45.98%
Holding current value
$1,398
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$11.96 - $15.71 $478 - $628
40 Added 45.98%
127 $1,000
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $987 - $1,455
87 New
87 $1,000
Q3 2023

Nov 21, 2023

BUY
$6.27 - $8.15 $3,260 - $4,238
520 New
520 $3,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.